SEC Form 4 research
| Issuer | Matinas BioPharma Holdings, Inc. |
|---|---|
| Tickers | MTNB |
| Reporting owners | 31 |
| Officers and directors | 10 |
| Last public filing | 2026-11-06 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-06 | 2026-11-06 | Murphy Keith | A | 5,000 | $0 | Not reported |
| 2026-11-06 | 2026-11-06 | D An Evelyn | A | 5,000 | $0 | Not reported |
| 2026-11-06 | 2026-11-06 | NEUGEBOREN EDWARD | A | 5,000 | $0 | Not reported |
| 2026-08-13 | 2026-07-10 | STERN ADAM K | A | 344,710 | $0.35 | Not reported |
| 2026-08-13 | 2026-07-10 | STERN ADAM K | A | 630,335 | $0.35 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.